Advertisement
U.S. markets open in 4 hours 32 minutes
  • S&P Futures

    5,305.75
    -2.50 (-0.05%)
     
  • Dow Futures

    40,149.00
    +5.00 (+0.01%)
     
  • Nasdaq Futures

    18,490.50
    -13.25 (-0.07%)
     
  • Russell 2000 Futures

    2,134.50
    -3.90 (-0.18%)
     
  • Crude Oil

    81.69
    +0.34 (+0.42%)
     
  • Gold

    2,216.60
    +3.90 (+0.18%)
     
  • Silver

    24.57
    -0.19 (-0.76%)
     
  • EUR/USD

    1.0793
    -0.0036 (-0.33%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.96
    +0.18 (+1.41%)
     
  • GBP/USD

    1.2606
    -0.0032 (-0.25%)
     
  • USD/JPY

    151.4350
    +0.1890 (+0.12%)
     
  • Bitcoin USD

    70,640.55
    +1,033.42 (+1.48%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,957.36
    +25.38 (+0.32%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Is Acadia Healthcare Company (ACHC) a Great Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Acadia Healthcare Company, Inc. ACHC stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, Acadia Healthcare Company has a trailing twelve months PE ratio of 14.8, as you can see in the chart below:



This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 compares in at about 20.2. If we focus on the stock’s long-term PE trend, the current level puts Acadia Healthcare Company’s current PE ratio noticeably below its midpoint (which is 25.4) over the past five years.



Further, the stock’s PE also compares favorably with the industry’s trailing twelve months PE ratio, which stands at 16.2. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.



We should also point out that Acadia Healthcare Company has a forward PE ratio (price relative to this year’s earnings) of just 14.1, so it is fair to say that a slightly more value-oriented path may be ahead for Acadia Healthcare Company’s stock in the near term too.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, Acadia Healthcare Company has a P/S ratio of about 1.1. This is substantially lower than the S&P 500 average, which comes in at 3.5 right now. Also, as we can see in the chart below, this is somewhat below the highs for this stock in particular over the past few years.



If anything, this suggests some level of undervalued trading—at least compared to historical norms. 
 
Broad Value Outlook

In aggregate, Acadia Healthcare Company currently has a Value Style Score of A, putting it into the top 20% of all stocks we cover from this look. This makes ACHC a solid choice for value investors.

What About the Stock Overall?

Though Acadia Healthcare Company might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth grade of C and a Momentum score of D. This gives ACHC a VGM score—or its overarching fundamental grade—of A. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been disappointing. The current quarter has seen seven estimates go lower in the past sixty days, compared to none higher, while the full year estimate has seen nine downward and one upward revision in the same time period.

This has had a noticeable impact on the consensus estimate, as the current quarter consensus estimate has fallen about 4.4% in the past two months, while the full year estimate has declined nearly 2.7%. You can see the consensus estimate trend and recent price action for the stock in the chart below:

Acadia Healthcare Company, Inc. Price and Consensus

 

Acadia Healthcare Company, Inc. Price and Consensus | Acadia Healthcare Company, Inc. Quote

This bearish trend is why the stock has just a Zacks Rank #3 (Hold) and why we are looking for in-line performance from the company in the near term.

Bottom Line

Acadia Healthcare Company is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Moreover, a strong industry rank (top 35% out of more than 250 industries) further supports the growth potential of the stock. However, with a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past two years, the sector has clearly underperformed the broader market, as you can see below:



So, value investors might want to wait for estimates and analyst sentiment to turn favorable in this name first, but once that happens, this stock could be a compelling pick.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement